Valsartan Tablet
Product Images NDC 72789-281

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 72789-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789281 Label (72789281)

72789281 Label (72789281)
Label for valsartan USP 160 mg oral tablets by PD-Rx Pharmaceuticals, Inc. The label indicates 60 film-coated tablets per container. It includes the NDC 72789-281-60, lot number J22A93, expiration date 08/2023, and a QR code. Directions for use fields are present but blank, with warnings and storage instructions highlighted.*
FDA Label Image

Figure01 (Fig01)

Figure01 (Fig01)
A forest plot comparing subgroups of patients between valsartan and captopril. The vertical axis lists subgroups such as age, gender, race, location, and beta-blocker use with corresponding patient percentages. Horizontal lines represent confidence intervals around point estimates on a scale from 0.5 (favors valsartan) to 1.5 (favors captopril). The plot visualizes the relative effect of valsartan versus captopril in each subgroup.*
FDA Label Image

Structuralformula (Structure)

Structuralformula (Structure)
Chemical structure of valsartan, the active ingredient shown in a 2D molecular diagram detailing its chemical bonds and groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.